TFS Capital’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,583
Closed -$54K 387
2017
Q2
$54K Buy
+2,583
New +$55.4K 0.02% 585
2016
Q3
Sell
-1,154
Closed -$21K 1027
2016
Q2
$21K Buy
+1,154
New +$30.7K ﹤0.01% 936
2016
Q1
Sell
-894
Closed -$32K 1115
2015
Q4
$32K Buy
+894
New +$38.8K ﹤0.01% 721
2013
Q3
Sell
-2,340
Closed -$171K 1657
2013
Q2
$171K Buy
+2,340
New +$135K 0.01% 1364

Other funds holding ALIM

TFS Capital's ALIM Position: Q3 2017 in Review

TFS Capital sold out of Alimera Sciences (ALIM) in Q3 2017, closing a stake of 2,583 shares — an estimated $54K sold.

TFS Capital first reported a position in ALIM in Q2 2013 and held it in 4 quarters. The position peaked at $171K in Q2 2013. 41 funds tracked by Wall St. Rank hold ALIM as of Q3 2017.

  • TFS Capital reported no remaining Alimera Sciences position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 2,583 Alimera Sciences shares in Q3 2017, an estimated $54K.
  • TFS Capital first reported a position in Alimera Sciences in Q2 2013 and held it in 4 quarters.
  • TFS Capital's Alimera Sciences position peaked at $171K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.